DHA PH II seql proposal H2S-0045, title: broad-spectrum snakebite antidote: metalloprotease inhibition to improve recovery time following snakebite, medical R & D EGS 23000510
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0061
- Awardee
-
Ophirex, Inc. UEI W452WY5E2JQ9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,299,779
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $1,299,779.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Corte Madera, CA 94925, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,299,779 |
About this award
Ophirex, Inc. has been awarded a firm fixed price definitive contract valued at $1,299,779 by the Department of the Army Medical Command. This contract is a Small Business Innovation Research Program Phase II award to further develop Ophirex's intravenous snakebite antidote varespladib. Specifically, the contract aims to improve recovery time following snakebite through metalloprotease inhibition. As a total small business set aside, this award will support Ophirex's continued medical research and development efforts toward a broad-spectrum treatment for snakebite envenomation. Work will be performed by Ophirex in Corte Madera, California through the projected period of performance completion date of December 2025.
Quick answers
Who was awarded contract HT942523C0061?
HT942523C0061 was awarded to Ophirex, Inc. by Defense Health Agency (Department of Defense) on August 25, 2023.
How much is contract HT942523C0061 worth?
The government has obligated $1,299,779 on HT942523C0061.
Which agency awarded contract HT942523C0061?
Defense Health Agency (Department of Defense) awarded HT942523C0061, with funding from Medical Command (Department of the Army).
Was contract HT942523C0061 competed?
The extent of competition for HT942523C0061 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award